NCT03129893

Brief Summary

The CDC definition was used to identify patients with VAP and VAT. The CDC definition of VAP for infants \< 1 y.o. and children \> 1 or \< 12 y.o. are based on clinical and X-ray criteria. The CDC definition of Tracheitis are based on absence of clinical and radiographic evidence of pneumonia and the following criteria: positive culture obtained by deep tracheal aspirate and 2 signs of symptoms with no recognizable cause \[such as fever (\>38.5°C), cough, new or increased sputum production, rhonchi, or wheezing\]. The new CDC definition is used to identify patients with VAC and IVAC. The new definitions includes all associated complications (infection included) related to mechanical ventilation and exclude X-ray criteria. VAP, VAT, VAC, IVAC rate, expressed as the number of VAP/VAT/VAC/IVAC episodes per 1000 mechanical ventilator days (VAP/1000 MV days), were calculated for phase 1 and phase 2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
242

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 26, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

August 3, 2023

Status Verified

August 1, 2023

Enrollment Period

2.2 years

First QC Date

March 1, 2017

Last Update Submit

August 2, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence rate difference of VAP and VAT between microcuffed TTs and uncuffed TTs

    The incidence rate difference of VAP and VAT between microcuffed TTs and uncuffed TTs

    At PICU discharge, an average of 2 weeks

Secondary Outcomes (5)

  • The incidence rate difference of VAC and IVAC

    At PICU discharge, an average of 2 weeks

  • The reintubation rates for leakage

    At PICU discharge, an average of 2 weeks

  • The post-extubation airway morbidity (post-extubation stridor)

    At PICU discharge, an average of 2 weeks

  • The duration of intubation

    At PICU discharge, an average of 2 weeks

  • The length of PICU stay

    At PICU discharge, an average of 2 weeks

Study Arms (2)

Patients intubated with uncuffed tracheal tubes

Portex uncuffed TT sizes selected according to local institutional guidelines. Tracheal intubation performed under direct laryngoscopy by the oral or nasal route, without or with the use of bougies or stylets. TT insertion depth managed according to institutional guidelines in uncuffed TTs.

Patients intubated with cuffed tracheal tubes

Cuffed TT sizes selected as follows: ID 3.0 mm for birth (\>3 kg body weight) to \< 8 months; ID 3.5 mm for 8 to \< 12 months (Salgo, Schmitz et al. 2006). Tracheal intubation performed under direct laryngoscopy by the oral or nasal route, without or with the use of bougies or stylets. TT insertion depth managed according to the depth marking in cuffed TTs.

Device: Cuffed tracheal tubes

Interventions

Cuffed tracheal tube with an anatomically designed high volume - low pressure tube cuff, with a recommendation chart for tube size selection available for pediatric anesthesia

Patients intubated with cuffed tracheal tubes

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patient in need intubation for cardiac surgery and transferred to the PICU.

You may qualify if:

  • Neonates \>35/40 gestation;
  • Expected to require ventilation for \> 24 hours;
  • Age: 0 - 5 year.

You may not qualify if:

  • Parents refused consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric intensive care unit - ASST Papa Giovanni XXIII

Bergamo, BG, 24127, Italy

Location

Study Officials

  • Mirco Nacoti, MD

    ASST Papa Giovanni XXIII di Bergamo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2017

First Posted

April 26, 2017

Study Start

January 1, 2017

Primary Completion

March 8, 2019

Study Completion

June 30, 2019

Last Updated

August 3, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations